GBI Research

Report: Parkinson’s treatment pipeline targeting functional processes over genes

Thursday, December 4, 2014 12:35 PM

The Parkinson’s disease (PD) treatment pipeline is characterized by a high degree of innovation and diverse molecular targets, with 37% of 302 products holding first-in-class status, according to New York-based business intelligence provider GBI Research.

More... »


Report: AML treatment market to witness modest growth by 2020

Wednesday, November 26, 2014 11:53 AM

The value of the global acute myeloid leukemia (AML) therapeutics market will increase moderately from $632.6 million in 2013 to $878.6 million by 2020, representing a Compound Annual Growth Rate (CAGR) of 4.8%, according to New York-based business intelligence provider GBI Research.

More... »


South and Central America API market closing gap on northern neighbors

Wednesday, August 22, 2012 09:57 AM
The active pharmaceutical ingredients (API) market in the Americas was worth a staggering $46 billion in 2011, with North America accounting for over 88% of it. But due to rapidly expanding economies and improvements in healthcare, South and Central America (SCA) are set to take a more substantial chunk in the future, according to a new report from GBI Research, a pharmaceutical industry analyst.

More... »

Standardized trial endpoints to help health authorities tackle respiratory diseases

Wednesday, June 20, 2012 12:16 PM

Science is standardizing the way respiratory health is measured, helping to judge the effectiveness of drug treatments better than ever, according to a new report by healthcare experts GBI Research.

More... »

Report: Orphan drug market on the rise

Thursday, May 24, 2012 09:00 AM

GBI Research, a pharmaceutical market expert, has released its report "Orphan Disease Therapeutics Market to 2018: Improved Understanding of Rare Diseases' Heterogeneity and Novel New Clinical Trial Designs to Foster Innovation,” which provides insights into the orphan disease therapeutics market until 2018.

More... »

CenterWatch Data Library
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

December 15

Cancer Treatment Centers of America chooses WCG as its exclusive IRB, sheds five local hospital IRBs

Five southern research groups form public-private network to help save time, money for clients with early-stage biologics

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

December

Growing adoption of feasibility review committees
Early reports cite fewer amendments, improved cycle time

AMCs vying to better compete for industry trials
Working to conquer study start-up delays, IRB review process

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

November

Private equity driving dynamic CRO growth
Enables CROs to pursue long-term strategies, while giving the space credibility

Baby boomers poised to reshape clinical trials industry
Millions of tech-savvy consumers already track their health, expect new treatments as they age

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs